Lambert-Eaton syndrome antibodies inhibit acetylcholine release and P/Q-type Ca2+ channels in electric ray nerve endings

Journal of Physiology

Volumn 508, Issue 2, 1998, Pages 427-438

  Satoh, Yasushi ^a   Hirashima, Naohide ^a   Tokumaru, Hiroshi ^a   Takahashi, Masanori P ^b,d   Kang, Jin ^b   Viglione, Michael P ^c   Kim, Yong I ^c   Kirino, Yutaka ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TONEYAMA NATIONAL HOSPITAL   (Japan)

^c UNIVERSITY OF VIRGINIA   (United States)

^d OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AUTOANTIBODY; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; IMMUNOGLOBULIN G ANTIBODY; IONOMYCIN; OMEGA CONOTOXIN; OMEGA CONOTOXIN GVIA; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; IMMUNOGLOBULIN G;

ACETYLCHOLINE RELEASE; ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CATTLE; CHROMAFFIN CELL; CONTROLLED STUDY; DEPOLARIZATION; EATON LAMBERT SYNDROME; EXOCYTOSIS; HUMAN; NERVE ENDING; NEUROMUSCULAR DISEASE; NONHUMAN; PRIORITY JOURNAL; SYNAPTOSOME; TORPEDO; ANIMAL CELL; ANTIBODY SPECIFICITY; CHOLINERGIC NERVE; DOWN REGULATION; ELECTRIC CAPACITANCE; ELECTROPHYSIOLOGY; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; MEMBRANE DEPOLARIZATION; MORPHOLOGY; NARKE JAPONICA;

EID: 0032522599     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-7793.1998.427bq.x     Document Type: Article

References (45)

1. AHMAD, S. N. & MILJANICH, G. P. (1988). The calcium channel antagonist, ω-conotoxin, and electric organ nerve terminals: binding and inhibition of transmitter release and calcium influx. Brain Research 453, 247-256.
2. 2+ concentrations. Pflügers Archiv 432, 1030-1038.
3. CHAPMAN, J., RABINOWITZ, R., KORCZYN, A. D. & MICHAELSON, D. M. (1990). Rats immunized with cholinergic synaptosomes: A model for Lambert-Eaton syndrome. Muscle and Nerve 13, 726-733.
4. DE AIZPURUA, H. J., LAMBERT, E. H., GRIESMAN, G. E., OLIVERA, B. M. & LENNON, V. A. (1988). Antagonism of voltage-gated calcium channels in small cell carcinomas of patients with and without Lambert-Eaton myasthenic syndrome by autoantibodies ω-conotoxin and adenosine. Cancer Research 48, 4719-4724.
5. DUNANT, Y. & MULLER, D. (1986). Quantal release of acetylcholine evoked by focal depolarization at the Torpedo nerve-electroplaque junction. Journal of Physiology 379, 461-478.
6. ELMQVIST, D. & LAMBERT, E. H. (1968). Detailed analysis of neuromuscular transmission in a patient with the myasthenic syndrome sometimes associated with bronchogenic carcinoma. Mayo Clinic Proceedings 43, 689-713.
7. FARIÑAS, I., SOLSONA, C. & MARSAL, J. (1992). Omega-conotoxin differentially blocks acetylcholine and adenosine triphosphate releases from Torpedo synaptosomes. Neuroscience 47, 641-648.
8. FUKUNAGA, H., ENGEL, A. G., OSAME, M. & LAMBERT E. H. (1982). Paucity and disorganization of presynaptic membrane active zones in the Lambert-Eaton myasthenic syndrome. Muscle and Nerve 5, 686-697.
9. GARCIA, K. D. & BEAM, K. G. (1996). Reduction of calcium currents by Lambert-Baton syndrome sera: motoneurons are preferentially affected, and L-type currents are spared. Journal of Neuroscience 16, 4903-4913.
10. 2+ channels of human neurublastoma IMR32 cells by Lambert-Eaton myasthenic syndrome (LEMS) IgGs. Neuroscience Letters 181, 50-56.
11. HAJELA, R. K. & ATCHISON, W. D. (1995). The proteins synaptotagmin and syntaxin are not general targets of Lambert-Eaton Myasthenic Syndrome autoantibody. Journal of Neurochemistry 64, 1245-1251.
12. HAMILL, O. P., MARTY, A., NEHER, E., SAKMANN, B. & SIGWORTH, F. J. (1981). Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Archiv 391, 85-100.
13. HEWETT, S. J. & ATCHISON, W. D. (1992). Disruption of synaptosomal calcium channel function by Lambert-Eaton myasthenic immunoglobulin is serum-dependent. Brain Research 599, 317-323.
14. 1 subunits from the marine ray Discopyge ommata. Proceedings of the National Academy of Sciences of the USA 90, 3787-3791.
15. ISRAËL, M. & LESBATS, B. (1981). Continuous determination by a chemiluminescent method of acetylcholine release and compartmentation in Torpedo electric organ synaptosomes. Journal of Neurochemistry 37, 1475-1483.
16. JOHNSTON, I., LANG, B., LEYS, K. & NEWSOM-DAVIS, J. (1994). Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient. Neurology 44, 334-338.
17. KIM, Y. I., MIDDLEKAUFF, E. H., VIGLIONE, M. P., OKUTSU, J., SATOH, Y., HIRASHIMA, N. & KIRINO, Y. (1998). An autoimmune animal model of the Lambert-Eaton syndrome. Annals of the New York Academy of Sciences (in the Press).
18. KIM, Y. I. & NEHER, E. (1988). IgG from patients with Lambert-Eaton syndrome blocks voltage-dependent calcium channels. Science 239, 405-408.
19. LENNON, V. A., KRYZER, T. J., GRIESMANN, M. S., O'SUILLEABHAIN, P. E., WINDEBANK, A. J., WOPPMANN, A., MILJANICH, G. P. & LAMBERT, E. H. (1995). Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndrome. New England Journal of Medicine 332, 1467-1474.
20. LENNON, V. A. & LAMBERT, E. H. (1989). Autoantibodies bind sulubilized calcium channel-ω-conotoxin complexes from small cell lung carcinoma: A diagnostic aid for Lambert-Eaton myasthenic syndrome. Mayo Clinic Proceedings 64, 1498-1504.
21. LEVÊQUE, C., HOSHINO, T., DAVID, P., KASAI, Y.-S., LEYS, K., OMORI, A., LANG, B., ET FAR, O., SATO, K., MARTIN-MOUTOT, N., NEWSOM-DAVIS, J., TAKAHASHI, M. & SEAGAR, M. J. (1992). The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen. Proceedings of the National Academy of Sciences of the USA 89, 3625-3629.
22. LINDSTROM, J. (1979). Autoimmune response to acetylcholine receptors in myasthenia gravis and its animal model. In Advances in Immunology, vol. 27, ed. KUNKEL, H. G. & DIXON, F., pp. 1-50. Academic Press, New York.
23. MAMDANI, M. B., WALSH, R. L., RUBINO, F. A., BRANNEGAN, R. I. & HWANG, M. H. (1985). Autonomic dysfunction and Eaton-Lambert syndrome. Journal of the Autonomic Nervous System 12, 315-320.
24. MARTIN-MOUTOT, N., LANG. B., NEWSOM-DAVIS, J. & SEAGER. M. (1995). Binding of Lambert-Eaton myasthenic syndrome IgG to synaptosomal proteins does not correlate with an inhibition of calcium uptake. Neuroscience Letters 187, 115-118.
25. MERINEY, S. D., HULSIZER, S. C., LENNON, V. A. & GRINNELL, A. D. (1996). Lambert-Eaton syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma. Annals of Neurology 40, 739-749.
26. MINTZ, I. M., ADAMS, M. E. & BEAN, B. P. (1992). P-type calcium channels in rat central and peripheral neurons. Neuron 9, 85-95.
27. O'HORI, T., WANG, C.-Y., TOKUMARU, H., CHEN, L.-C., HATANAKA, K., HIRASHIMA, N. & KIRINO, Y. (1993). Action of binding of omega-conotoxin on the putative calcium channel of synaptosomal plasma membrane from electric organ of Japanese electric ray, Narke japonica. Neuroscience 54, 1043-1050.
28. O'NEILL, J. H., MURRAY, N. M. & NEWSOM-DAVIS, J. (1988). The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain 111, 577-596.
29. PEERS, C., JOHNSTON, I., LANG, B. & WRAY, D. (1993). Cross-linking of presynaptic calcium channels: a mechanism of action for Lambert-Eaton myasthenic syndrome antibodies at the mouse neuromuscular junction. Neuroscience Letters 153, 45-48.
30. PEERS, C., LANG, B., NEWSOM-DAVIS, J. & WRAY, D. (1990). Selective action of myasthenic syndrome antibodies on calcium channels in a rodent neuroblastoma x glioma cell line. Journal of Physiology 421, 293-308.
31. POCOCK, J. M., VENEMA, V. J. & ADAMS, M. E. (1992). ω-Agatoxins differentially block calcium channels in locust, chick and rat synaptosomes. Neurochemistry International 20, 263-270.
32. PROTTI, D. A., REISIN, R., MACKINLEY, T. A. & UCHITEL, O. D. (1996). Calcium channel blockers and transmitter release at the normal human neuromuscular junction. Neurology 46, 1391-1396.
33. 2+ currents blocked by the spider toxin omega-Aga-IVA. NeuroReport 5, 333-336.
34. 2+ flux in human small cell carcinoma line. Nature 317, 737-739.
35. 1 subunits. Neuron 11, 291-303.
36. SCHWEITZER, E. (1987). Coordinated release of ATP and ACh from cholinergic synaptosomes and its inhibition by calmodulin antagonists. Journal of Neuroscience 1, 2948-2956.
37. SHER, E., GOTTI, C., CANAL, N., SCOPPETTA, C., PICCOLO, G., EVOLI, A. & CLEMENTI, F. (1989). Specificity of calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome. Lancet 2, 640-643.
38. TAKAMORI, M., HAMADA, T., KOMAI, K., TAKAHASHI, M. & YOSHIDA, A. (1994). Synaptotagmin can cause an immune-mediated model of Lambert-Eaton myasthenic syndrome in rats. Annals of Neurology 35, 74-80.
39. TOKUMARU, H., SATOH, Y., HIRASHIMA, N., SHOJAKU, S., YAMAMOTO, H. & KIRINO, Y. (1997). Involvement of calciseptine-sensitive calcium channels in the evoked acetylcholine release from electric organ synaptosomes. Biological and Pharmaceutical Bulletin 20, 641-645.
40. 2δ subunit. Journal of Neurochemistry 65, 831-836.
41. TURNER, T. J., LAMPE, R. A. & DUNLAP, K. (1995). Characterization of presynaptic calcium channels with ω-conotoxin MVIIC and ω-grammotoxin SIA: Role for a resistant calcium channel type in neurosecretion. Molecular Pharmacology 47, 348-353.
42. VIGLIONE, M. P., O'SHAUGHNESSY, T. J. & KIM, Y. I. (1995). Inhibition of calcium currents and exocytosis by Lambert-Eaton syndrome antibodies in human lung cancer cells. Journal of Physiology 488, 303-317.
43. VINCENT, A., LANG, B. & NEWSOM-DAVIS, J. (1989). Autoimmunity to the voltage-gated calcium channels underlies the Lambert-Eaton syndrome, a paraneoplastic disorder. Trends in Neurosciences 12, 496-502.
44. WATERMAN, S. A., LANG, B. & NEWSOM-DAVIS, J. (1997). Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse. Annals of Neurology 42, 147-156.
45. WRAY, D. (1990). The Lambert-Eaton myasthenic syndrome. In Neuromuscular Transmission: Basic and Applied Aspects, ed. VINCENT, A. & WRAY, D., pp. 249-267, Manchester University Press, Manchester.